SCHEMBL23961998

SCHEMBL23961998

c1ccc2c(Oc3ncc4ncn(C5CCCCC5)c4n3)cccc2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCTR P47872 9/20 0.58
SMO Q99835 1/20 0.53
CYP1A2 P05177 3/20 0.39
ALDH1A1 P00352 3/20 0.39
CYP2C19 P33261 2/20 0.39
USP2 O75604 2/20 0.39
GLA P06280 1/20 0.39
AURKA O14965 1/20 0.39
JAK2 O60674 1/20 0.39
PRKCA P17252 1/20 0.39
JAK1 P23458 1/20 0.39
KDR P35968 1/20 0.39
JAK3 P52333 1/20 0.39
ACVR1 Q04771 1/20 0.36
PDE5A O76074 1/20 0.36
PDE1A P54750 1/20 0.36
PDE1B Q01064 1/20 0.36
PDE1C Q14123 1/20 0.36
CYP2C9 P11712 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31402481 0.73 SCTR (0.75) SCTRSMO
SCHEMBL16367807 0.72 SCTR (0.89) SCTRSMO
Purmorphamine SCHEMBL1548273 0.70 SCTR (1.00) SCTRSMO
Purmorphamine SCHEMBL29358352 0.70 SCTR (1.00) SCTRSMO
SCHEMBL14075696 0.69 SCTR (0.98) SCTRSMO
SCHEMBL28300768 0.69 AURKA (0.44) ALDH1A1AURKAJAK2PRKCAJAK1
SCHEMBL24978893 0.68 HTR1B (0.38) CYP1A2ALDH1A1CYP2C19
SCHEMBL14743315 0.67 ADORA2A (0.49) CYP1A2ALDH1A1AURKAJAK2PRKCA
SCHEMBL27438642 0.67 PI4KA (0.42) ALDH1A1AURKAJAK2PRKCAJAK1
SCHEMBL28234948 0.64 ADORA2A (0.42) ALDH1A1AURKAJAK2PRKCAJAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021216623-A1 GENE EDITING OF LRRK2 IN STEM CELLS AND METHOD OF USE OF CELLS DIFFERENTIATED THEREFROM ASPEN NEUROSCIENCE, INC. (US) 2021-10-28 WO disclosed